EU SCCS Issues Final Opinion on Acetophenone Safety

The European Union's Scientific Committee on Consumer Safety (SCCS) has issued a final opinion on acetophenone, a compound used as a fragrance ingredient in cosmetics and personal care products, according to a report from CIRS Group carried by Google News.

What is acetophenone used for in cosmetic products?

Acetophenone is an aromatic ketone most commonly associated with the fragrance and flavor industries, where it is used in small amounts to contribute scent or flavor notes, including in some cosmetic formulations. The SCCS periodically reviews ingredients already present in EU-marketed products, as well as new industry submissions, to determine whether current or proposed concentration limits adequately protect consumer health. The committee's review of acetophenone falls into that routine safety-assessment category, per the CIRS Group report.

What does a "final opinion" from the SCCS mean?

A final SCCS opinion follows an internal scientific review and comment process inside the committee, which functions as an independent advisory body supporting the European Commission's cosmetics regulation. Final opinions typically lay out the panel's risk assessment and, where applicable, recommend maximum concentrations or conditions of use for industry to follow. The CIRS Group report did not detail the specific concentration limits, exposure estimates, or toxicological findings behind this particular acetophenone opinion, and those figures could not be independently verified from the available report at the time of publication.

Why does the EU keep reassessing ingredients already in use?

The SCCS periodically revisits fragrance and preservative ingredients as new toxicological data, exposure modeling, or consumer-complaint patterns emerge, rather than waiting for a single comprehensive review. Earlier HTT News Science Desk reporting on skin care formulation has noted that ingredient reassessment of this kind is a routine regulatory function, not necessarily a signal that a product currently on shelves poses an immediate risk.

The CIRS Group report frames the acetophenone opinion as part of the SCCS's ordinary ingredient-review cycle rather than an emergency safety alert.

What happens next for cosmetic brands and formulators?

If the opinion revises an exposure limit, manufacturers that include acetophenone in notified cosmetic products sold in the EU would need to adjust formulations once the European Commission incorporates any new conditions into the EU Cosmetic Regulation framework. CIRS Group, a regulatory consultancy that tracks SCCS actions for industry clients, was among the outlets to flag the opinion's issuance, though the underlying technical document was not reproduced in full in the available report.

What to watch

• Publication of the SCCS's complete technical opinion, which would spell out any concentration limits for acetophenone in leave-on and rinse-off products.
• Whether the European Commission moves to fold the opinion into EU Cosmetic Regulation annexes governing restricted and permitted substances.
• Responses from fragrance-industry trade groups to any new conditions of use.
• Follow-up guidance for brands listing acetophenone or related aromatic ketones on ingredient labels.

Consumers who want to check a specific product can review its ingredient panel on packaging. An SCCS review does not, on its own, require brands to pull or reformulate products already on shelves unless and until the European Commission updates the regulation, consistent with the committee's standard review process described in the CIRS Group report.